HomeERNA • NASDAQ
add
Ernexa Therapeutics Inc
Previous close
$0.32
Day range
$0.28 - $0.32
Year range
$0.27 - $4.20
Market cap
8.83M USD
Avg Volume
2.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.09M | -22.39% |
Net income | -1.50M | 73.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.08M | 22.29% |
Effective tax rate | 3.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.88M | 8.96% |
Total assets | 5.83M | 10.72% |
Total liabilities | 3.43M | -3.78% |
Total equity | 2.40M | — |
Shares outstanding | 29.15M | — |
Price to book | 1.05 | — |
Return on assets | -87.21% | — |
Return on capital | -149.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.50M | 73.92% |
Cash from operations | -1.15M | 67.62% |
Cash from investing | -15.00K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.16M | 54.12% |
Free cash flow | -893.62K | 64.60% |
About
Founded
2018
Headquarters
Website
Employees
6
